Preparation, Characterization, and Hepatoprotective Activity Evaluation of Quercetin-loaded Pluronic ® F127/Chitosan-Myristic Acid Mixed Micelles
CONCLUSION: The findings demonstrate that developed QTN MM could be used as an alternative nanocarrier to increase the biopharmaceutical and hepatoprotective potential of QTN and other flavonoids.PMID:38500282 | DOI:10.2174/0115672018278618240304054731 (Source: Current Drug Delivery)
Source: Current Drug Delivery - March 19, 2024 Category: Drugs & Pharmacology Authors: Darshan R Telange Seema Kamdi Atul T Hemke Anil M Pethe Vijay B Lambole Umesh B Telrandhe Source Type: research

Preparation, Characterization, and Hepatoprotective Activity Evaluation of Quercetin-loaded Pluronic ® F127/Chitosan-Myristic Acid Mixed Micelles
CONCLUSION: The findings demonstrate that developed QTN MM could be used as an alternative nanocarrier to increase the biopharmaceutical and hepatoprotective potential of QTN and other flavonoids.PMID:38500282 | DOI:10.2174/0115672018278618240304054731 (Source: Current Drug Delivery)
Source: Current Drug Delivery - March 19, 2024 Category: Drugs & Pharmacology Authors: Darshan R Telange Seema Kamdi Atul T Hemke Anil M Pethe Vijay B Lambole Umesh B Telrandhe Source Type: research

Preparation, Characterization, and Hepatoprotective Activity Evaluation of Quercetin-loaded Pluronic ® F127/Chitosan-Myristic Acid Mixed Micelles
CONCLUSION: The findings demonstrate that developed QTN MM could be used as an alternative nanocarrier to increase the biopharmaceutical and hepatoprotective potential of QTN and other flavonoids.PMID:38500282 | DOI:10.2174/0115672018278618240304054731 (Source: Current Drug Delivery)
Source: Current Drug Delivery - March 19, 2024 Category: Drugs & Pharmacology Authors: Darshan R Telange Seema Kamdi Atul T Hemke Anil M Pethe Vijay B Lambole Umesh B Telrandhe Source Type: research

Preparation, Characterization, and Hepatoprotective Activity Evaluation of Quercetin-loaded Pluronic ® F127/Chitosan-Myristic Acid Mixed Micelles
CONCLUSION: The findings demonstrate that developed QTN MM could be used as an alternative nanocarrier to increase the biopharmaceutical and hepatoprotective potential of QTN and other flavonoids.PMID:38500282 | DOI:10.2174/0115672018278618240304054731 (Source: Current Drug Delivery)
Source: Current Drug Delivery - March 19, 2024 Category: Drugs & Pharmacology Authors: Darshan R Telange Seema Kamdi Atul T Hemke Anil M Pethe Vijay B Lambole Umesh B Telrandhe Source Type: research

Preparation, Characterization, and Hepatoprotective Activity Evaluation of Quercetin-loaded Pluronic ® F127/Chitosan-Myristic Acid Mixed Micelles
CONCLUSION: The findings demonstrate that developed QTN MM could be used as an alternative nanocarrier to increase the biopharmaceutical and hepatoprotective potential of QTN and other flavonoids.PMID:38500282 | DOI:10.2174/0115672018278618240304054731 (Source: Current Drug Delivery)
Source: Current Drug Delivery - March 19, 2024 Category: Drugs & Pharmacology Authors: Darshan R Telange Seema Kamdi Atul T Hemke Anil M Pethe Vijay B Lambole Umesh B Telrandhe Source Type: research

Preparation, Characterization, and Hepatoprotective Activity Evaluation of Quercetin-loaded Pluronic ® F127/Chitosan-Myristic Acid Mixed Micelles
CONCLUSION: The findings demonstrate that developed QTN MM could be used as an alternative nanocarrier to increase the biopharmaceutical and hepatoprotective potential of QTN and other flavonoids.PMID:38500282 | DOI:10.2174/0115672018278618240304054731 (Source: Current Drug Delivery)
Source: Current Drug Delivery - March 19, 2024 Category: Drugs & Pharmacology Authors: Darshan R Telange Seema Kamdi Atul T Hemke Anil M Pethe Vijay B Lambole Umesh B Telrandhe Source Type: research

Preparation, Characterization, and Hepatoprotective Activity Evaluation of Quercetin-loaded Pluronic ® F127/Chitosan-Myristic Acid Mixed Micelles
CONCLUSION: The findings demonstrate that developed QTN MM could be used as an alternative nanocarrier to increase the biopharmaceutical and hepatoprotective potential of QTN and other flavonoids.PMID:38500282 | DOI:10.2174/0115672018278618240304054731 (Source: Current Drug Delivery)
Source: Current Drug Delivery - March 19, 2024 Category: Drugs & Pharmacology Authors: Darshan R Telange Seema Kamdi Atul T Hemke Anil M Pethe Vijay B Lambole Umesh B Telrandhe Source Type: research

Recent Trends and Applications of Nanostructure-based Drug Delivery in Alleviating Chronic Obstructive Pulmonary Disease (COPD)
Curr Drug Deliv. 2024 Mar 5. doi: 10.2174/0115672018289883240226113353. Online ahead of print.ABSTRACTChronic Obstructive Pulmonary Disease (COPD), a chronic lung disease that causes breathing difficulties and obstructs airflow from the lungs, has a significant global health burden and affects millions of people worldwide. The use of pharmaceuticals in COPD treatment is aimed to alleviate symptoms, improve lung function, prevent exacerbations, and enhance the overall quality of life for patients. Nanotechnology holds great promise to alleviate the burden of COPD. The main goal of this review is to present the full spectrum...
Source: Current Drug Delivery - March 6, 2024 Category: Drugs & Pharmacology Authors: None Lokesh Nisha Gulati Annu Saini Sachin Singh Gaurav Gupta Ronan MacLoughlin Dinesh Kumar Chellappan Kamal Dua Harish Dureja Source Type: research

Advances in Aerosol Formulation for Targeted Delivery of Therapeutic Agents from Nose to Brain
Curr Drug Deliv. 2024 Mar 5. doi: 10.2174/0115672018285350240227073607. Online ahead of print.ABSTRACTThe intricate anatomical and physiological barriers that prohibit pharmaceuticals from entering the brain continue to provide a noteworthy hurdle to the efficient distribution of medications to brain tissues. These barriers prevent the movement of active therapeutic agents into the brain. The present manuscript aims to describe the various aspects of brain-targeted drug delivery through the nasal route. The primary transport mechanism for drug absorption from the nose to the brain is the paracellular/extracellular mechanis...
Source: Current Drug Delivery - March 6, 2024 Category: Drugs & Pharmacology Authors: Shristy Verma Pramod Kumar Sharma Rishabha Malviya Source Type: research

Recent Trends and Applications of Nanostructure-based Drug Delivery in Alleviating Chronic Obstructive Pulmonary Disease (COPD)
Curr Drug Deliv. 2024 Mar 5. doi: 10.2174/0115672018289883240226113353. Online ahead of print.ABSTRACTChronic Obstructive Pulmonary Disease (COPD), a chronic lung disease that causes breathing difficulties and obstructs airflow from the lungs, has a significant global health burden and affects millions of people worldwide. The use of pharmaceuticals in COPD treatment is aimed to alleviate symptoms, improve lung function, prevent exacerbations, and enhance the overall quality of life for patients. Nanotechnology holds great promise to alleviate the burden of COPD. The main goal of this review is to present the full spectrum...
Source: Current Drug Delivery - March 6, 2024 Category: Drugs & Pharmacology Authors: None Lokesh Nisha Gulati Annu Saini Sachin Singh Gaurav Gupta Ronan MacLoughlin Dinesh Kumar Chellappan Kamal Dua Harish Dureja Source Type: research

Advances in Aerosol Formulation for Targeted Delivery of Therapeutic Agents from Nose to Brain
Curr Drug Deliv. 2024 Mar 5. doi: 10.2174/0115672018285350240227073607. Online ahead of print.ABSTRACTThe intricate anatomical and physiological barriers that prohibit pharmaceuticals from entering the brain continue to provide a noteworthy hurdle to the efficient distribution of medications to brain tissues. These barriers prevent the movement of active therapeutic agents into the brain. The present manuscript aims to describe the various aspects of brain-targeted drug delivery through the nasal route. The primary transport mechanism for drug absorption from the nose to the brain is the paracellular/extracellular mechanis...
Source: Current Drug Delivery - March 6, 2024 Category: Drugs & Pharmacology Authors: Shristy Verma Pramod Kumar Sharma Rishabha Malviya Source Type: research

Recent Trends and Applications of Nanostructure-based Drug Delivery in Alleviating Chronic Obstructive Pulmonary Disease (COPD)
Curr Drug Deliv. 2024 Mar 5. doi: 10.2174/0115672018289883240226113353. Online ahead of print.ABSTRACTChronic Obstructive Pulmonary Disease (COPD), a chronic lung disease that causes breathing difficulties and obstructs airflow from the lungs, has a significant global health burden and affects millions of people worldwide. The use of pharmaceuticals in COPD treatment is aimed to alleviate symptoms, improve lung function, prevent exacerbations, and enhance the overall quality of life for patients. Nanotechnology holds great promise to alleviate the burden of COPD. The main goal of this review is to present the full spectrum...
Source: Current Drug Delivery - March 6, 2024 Category: Drugs & Pharmacology Authors: None Lokesh Nisha Gulati Annu Saini Sachin Singh Gaurav Gupta Ronan MacLoughlin Dinesh Kumar Chellappan Kamal Dua Harish Dureja Source Type: research

Advances in Aerosol Formulation for Targeted Delivery of Therapeutic Agents from Nose to Brain
Curr Drug Deliv. 2024 Mar 5. doi: 10.2174/0115672018285350240227073607. Online ahead of print.ABSTRACTThe intricate anatomical and physiological barriers that prohibit pharmaceuticals from entering the brain continue to provide a noteworthy hurdle to the efficient distribution of medications to brain tissues. These barriers prevent the movement of active therapeutic agents into the brain. The present manuscript aims to describe the various aspects of brain-targeted drug delivery through the nasal route. The primary transport mechanism for drug absorption from the nose to the brain is the paracellular/extracellular mechanis...
Source: Current Drug Delivery - March 6, 2024 Category: Drugs & Pharmacology Authors: Shristy Verma Pramod Kumar Sharma Rishabha Malviya Source Type: research

Recent Trends and Applications of Nanostructure-based Drug Delivery in Alleviating Chronic Obstructive Pulmonary Disease (COPD)
Curr Drug Deliv. 2024 Mar 5. doi: 10.2174/0115672018289883240226113353. Online ahead of print.ABSTRACTChronic Obstructive Pulmonary Disease (COPD), a chronic lung disease that causes breathing difficulties and obstructs airflow from the lungs, has a significant global health burden and affects millions of people worldwide. The use of pharmaceuticals in COPD treatment is aimed to alleviate symptoms, improve lung function, prevent exacerbations, and enhance the overall quality of life for patients. Nanotechnology holds great promise to alleviate the burden of COPD. The main goal of this review is to present the full spectrum...
Source: Current Drug Delivery - March 6, 2024 Category: Drugs & Pharmacology Authors: None Lokesh Nisha Gulati Annu Saini Sachin Singh Gaurav Gupta Ronan MacLoughlin Dinesh Kumar Chellappan Kamal Dua Harish Dureja Source Type: research

Advances in Aerosol Formulation for Targeted Delivery of Therapeutic Agents from Nose to Brain
Curr Drug Deliv. 2024 Mar 5. doi: 10.2174/0115672018285350240227073607. Online ahead of print.ABSTRACTThe intricate anatomical and physiological barriers that prohibit pharmaceuticals from entering the brain continue to provide a noteworthy hurdle to the efficient distribution of medications to brain tissues. These barriers prevent the movement of active therapeutic agents into the brain. The present manuscript aims to describe the various aspects of brain-targeted drug delivery through the nasal route. The primary transport mechanism for drug absorption from the nose to the brain is the paracellular/extracellular mechanis...
Source: Current Drug Delivery - March 6, 2024 Category: Drugs & Pharmacology Authors: Shristy Verma Pramod Kumar Sharma Rishabha Malviya Source Type: research